![]() |
Volumn 21, Issue 5, 2007, Pages 426-
|
Paliperidone extended release: A viewpoint
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PALIPERIDONE;
PLACEBO;
PROLACTIN;
QUETIAPINE;
RISPERIDONE;
ZIPRASIDONE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ACTIVITY;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MEGADOSE;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
NOTE;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
SCHIZOPHRENIA;
SIDE EFFECT;
|
EID: 34247859293
PISSN: 11727047
EISSN: None
Source Type: Journal
DOI: 10.2165/00023210-200721050-00006 Document Type: Note |
Times cited : (1)
|
References (0)
|